Literature DB >> 32948835

Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning.

Akira Saito1,2, Hidenori Toyoda3, Masaharu Kobayashi4, Yoshinori Koiwa4, Hiroki Fujii4, Koji Fujita1, Atsuyuki Maeda5, Yuji Kaneoka5, Shoichi Hazama6, Hiroaki Nagano7, Aashiq H Mirza1,8, Hans-Peter Graf9, Eric Cosatto9, Yoshiki Murakami10, Masahiko Kuroda11.   

Abstract

Hepatocellular carcinoma (HCC) is a representative primary liver cancer caused by long-term and repetitive liver injury. Surgical resection is generally selected as the radical cure treatment. Because the early recurrence of HCC after resection is associated with low overall survival, the prediction of recurrence after resection is clinically important. However, the pathological characteristics of the early recurrence of HCC have not yet been elucidated. We attempted to predict the early recurrence of HCC after resection based on digital pathologic images of hematoxylin and eosin-stained specimens and machine learning applying a support vector machine (SVM). The 158 HCC patients meeting the Milan criteria who underwent surgical resection were included in this study. The patients were categorized into three groups: Group I, patients with HCC recurrence within 1 year after resection (16 for training and 23 for test); Group II, patients with HCC recurrence between 1 and 2 years after resection (22 and 28); and Group III, patients with no HCC recurrence within 4 years after resection (31 and 38). The SVM-based prediction method separated the three groups with 89.9% (80/89) accuracy. Prediction of Groups I was consistent for all cases, while Group II was predicted to be Group III in one case, and Group III was predicted to be Group II in 8 cases. The use of digital pathology and machine learning could be used for highly accurate prediction of HCC recurrence after surgical resection, especially that for early recurrence. Currently, in most cases after HCC resection, regular blood tests and diagnostic imaging are used for follow-up observation; however, the use of digital pathology coupled with machine learning offers potential as a method for objective postoprative follow-up observation.

Entities:  

Year:  2020        PMID: 32948835     DOI: 10.1038/s41379-020-00671-z

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

1.  A Hybrid Machine Learning Model Based on Semantic Information Can Optimize Treatment Decision for Naïve Single 3-5-cm HCC Patients.

Authors:  Wenzhen Ding; Zhen Wang; Fang-Yi Liu; Zhi-Gang Cheng; Xiaoling Yu; Zhiyu Han; Hui Zhong; Jie Yu; Ping Liang
Journal:  Liver Cancer       Date:  2022-01-28       Impact factor: 12.430

Review 2.  Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma.

Authors:  Julien Calderaro; Tobias Paul Seraphin; Tom Luedde; Tracey G Simon
Journal:  J Hepatol       Date:  2022-06       Impact factor: 30.083

Review 3.  Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities.

Authors:  Chrysanthos D Christou; Georgios Tsoulfas
Journal:  World J Gastrointest Oncol       Date:  2022-04-15

4.  The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment.

Authors:  Bong Kyung Bae; Hee Chul Park; Gyu Sang Yoo; Moon Seok Choi; Joo Hyun Oh; Jeong Il Yu
Journal:  Cancers (Basel)       Date:  2022-04-21       Impact factor: 6.575

5.  Development of Models to Predict Postoperative Complications for Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Mingyang Bao; Qiuyu Zhu; Tuerganaili Aji; Shuyao Wei; Talaiti Tuergan; Xiaoqin Ha; Alimu Tulahong; Xiaoyi Hu; Yueqing Hu
Journal:  Front Oncol       Date:  2021-10-05       Impact factor: 6.244

Review 6.  Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.

Authors:  David Nam; Julius Chapiro; Valerie Paradis; Tobias Paul Seraphin; Jakob Nikolas Kather
Journal:  JHEP Rep       Date:  2022-02-02

7.  Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features.

Authors:  Naoto Tokuyama; Akira Saito; Ryu Muraoka; Shuya Matsubara; Takeshi Hashimoto; Naoya Satake; Jun Matsubayashi; Toshitaka Nagao; Aashiq H Mirza; Hans-Peter Graf; Eric Cosatto; Chin-Lee Wu; Masahiko Kuroda; Yoshio Ohno
Journal:  Mod Pathol       Date:  2021-10-29       Impact factor: 7.842

8.  Deep Learning-Based Universal Expert-Level Recognizing Pathological Images of Hepatocellular Carcinoma and Beyond.

Authors:  Wei-Ming Chen; Min Fu; Cheng-Ju Zhang; Qing-Qing Xing; Fei Zhou; Meng-Jie Lin; Xuan Dong; Jiaofeng Huang; Su Lin; Mei-Zhu Hong; Qi-Zhong Zheng; Jin-Shui Pan
Journal:  Front Med (Lausanne)       Date:  2022-04-22

9.  Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study.

Authors:  Jae Hyun Yoon; Sung Kyu Choi; Sung Bum Cho; Hee Joon Kim; Yang Seok Ko; Chung Hwan Jun
Journal:  World J Gastroenterol       Date:  2022-09-28       Impact factor: 5.374

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.